abstract |
The present application relates to a 2,3-dihydro-1H-pyrroleazine-7-carboxamide derivative as a nucleoprotein inhibitor, and its application in the preparation of a medicine for treating HBV-related diseases. Specifically, it relates to the compound represented by formula (II), its isomer or its pharmaceutically acceptable salt. |